BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27386062)

  • 1. The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping.
    Moazami-Goudarzi M; Farshdousti-Hagh M; Hoseinpour-Feizi A; Talebi M; Movassaghpour-Akbari AA; Shams-Asanjan K; Eyvazi-Ziyaee J; Seifi M
    Caspian J Intern Med; 2016; 7(2):105-13. PubMed ID: 27386062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (
    Moawadh MS; Mir R; Tayeb FJ; Asim O; Ullah MF
    Curr Issues Mol Biol; 2023 May; 45(5):3933-3952. PubMed ID: 37232720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of
    Nikmohammadi N; Sarbakhsh P; Moazami Goudarzi M; Talebi M; Farshdousti-Hagh M; Malakouti J; Gilani N
    Iran J Public Health; 2022 Apr; 51(4):895-903. PubMed ID: 35936524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetic polymorphisms in apoptosis-related genes and risk of cutaneous melanoma in women and men.
    Oliveira C; Lourenço GJ; Rinck-Junior JA; Cintra ML; Moraes AM; Lima CS
    J Dermatol Sci; 2014 May; 74(2):135-41. PubMed ID: 24461648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Bax gene polymorphisms and esophagus cancer.
    Sun L; Wei L; Wei L; Li D
    Oncol Lett; 2018 Dec; 16(6):7097-7101. PubMed ID: 30546444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms of cathepsin S and the risks of asthma attack induced by acaroid mites.
    Li C; Chen Q; Jiang Y; Liu Z
    Int J Clin Exp Med; 2015; 8(1):1178-87. PubMed ID: 25785111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
    Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
    Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of regulatory promoter polymorphism (-248 G>A) of Bax gene in patients with gastric cancer in the northern provinces of Iran.
    Mirmajidi SH; Najafi M; Mirmajidi ST; Nasri Nasrabadi N
    Gastroenterol Hepatol Bed Bench; 2016; 9(1):36-44. PubMed ID: 26744613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
    Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
    Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia.
    Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Sadegh MH; Nematollahi MH; Rezaei M; Rasouli A; Eskandari F; Heydarabad MZ; Teimoori B; Salimi S
    Apoptosis; 2019 Apr; 24(3-4):301-311. PubMed ID: 30701356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-based polymorphisms in members of the apoptosis Bcl-2 gene family and their association with hematocrit level.
    Zeng SM; Yankowitz J; Widness JA; Strauss RG
    J Gend Specif Med; 2003; 6(4):36-42. PubMed ID: 14714449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
    Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
    Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
    Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
    Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
    Leukemia; 2006 Jan; 20(1):77-81. PubMed ID: 16307023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.